Follow-up of renal cell carcinoma in a nonmetastatic stage

被引：0
作者：
Szabados, B. [1 ]
Foller, S. [2 ]
Schulz, G. B. [3 ]
Staehler, M. [3 ]
Grimm, M. -O. [2 ]
Stief, C. G. [3 ]
Casuscelli, J. [3 ]
机构：
[1] Queen Mary Univ London, Barts Canc Inst, London, England
[2] Univ Klinikum Jena, Klin Urol, Jena, Germany
[3] Klinikum Univ Munchen, Urol Klin & Poliklin, Campus Grosshadern,Marchioninistr 15, D-81377 Munich, Germany
来源：
UROLOGE | 2019年 / 58卷 / 01期
关键词：
Kidney neoplasms; Postoperative care; Complications; Relapse; Guidelines; NEPHRON-SPARING SURGERY; RADICAL NEPHRECTOMY; BRAIN METASTASIS; LATE RECURRENCE; SURVEILLANCE; GUIDELINES; VALIDATION; RISK; ASSOCIATION; PATTERNS;
D O I：
10.1007/s00120-018-0823-z
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Postoperative follow-up care after curative surgery or ablative treatment is the standard of care in patients with nonmetastatic renal cell carcinoma. The goal is to identify and treat postoperative complications and local recurrences early on. Follow-up investigations and their relevance are widely acknowledged and validated and patients undergoing follow-up seem to benefit from alonger survival in nonmetastatic renal cell carcinoma. Hence there is no consensus on a standardized follow-up strategy. The most disputed question is around the frequency of the investigations and the duration of the follow-up. Without an evidence-based follow-up protocol, urologists should carry out an individualized, potentially lifelong follow-up regimen, which also includes the patients' needs and perspectives.
引用
收藏
页码：65 / 76
页数：12
相关论文
共 32 条
  • [1] A prospective risk-stratified follow-up programme for radically treated renal cell carcinoma patients: evaluation after eight years of clinical use
    Beisland, Christian
    Gudbrandsdottir, Gigja
    Reisaeter, Lars A. R.
    Bostad, Leif
    Hjelle, Karin M.
    [J]. WORLD JOURNAL OF UROLOGY, 2016, 34 (08) : 1087 - 1099
  • [2] Features Associated with Recurrence Beyond 5 Years After Nephrectomy and Nephron-Sparing Surgery for Renal Cell Carcinoma: Development and Internal Validation of a Risk Model (PRELANE score) to Predict Late Recurrence Based on a Large Multicenter Database (CORONA/SATURN Project)
    Brookman-May, Sabine
    May, Matthias
    Shariat, Shahrokh F.
    Xylinas, Evanguelos
    Stief, Christian
    Zigeuner, Richard
    Chromecki, Thomas
    Burger, Maximilian
    Wieland, Wolf F.
    Cindolo, Luca
    Schips, Luigi
    De Cobelli, Ottavio
    Rocco, Bernardo
    De Nunzio, Cosimo
    Feciche, Bogdan
    Truss, Michael
    Gilfrich, Christian
    Pahernik, Sascha
    Hohenfellner, Markus
    Zastrow, Stefan
    Wirth, Manfred P.
    Novara, Giacomo
    Carini, Marco
    Minervini, Andrea
    Simeone, Claudio
    Antonelli, Alessandro
    Mirone, Vincenzo
    Longo, Nicola
    Simonato, Alchiede
    Carmignani, Giorgio
    Ficarra, Vincenzo
    [J]. EUROPEAN UROLOGY, 2013, 64 (03) : 472 - 477
  • [3] Renal cell carcinoma local recurrences: impact of surgical treatment and concomitant metastasis on survival
    Bruno, J. James, II
    Snyder, Mark E.
    Motzer, Robert J.
    Russo, Paul
    [J]. BJU INTERNATIONAL, 2006, 97 (05) : 933 - 938
  • [4] Genomic landscape and evolution of metastatic chromophobe renal cell carcinoma
    Casuscelli, Jozefina
    Weinhold, Nils
    Gundem, Gunes
    Wang, Lu
    Zabor, Emily C.
    Drill, Esther
    Wang, Patricia I.
    Nanjangud, Gouri J.
    Redzematovic, Almedina
    Nargund, Amrita M.
    Manley, Brandon J.
    Arcila, Maria E.
    Donin, Nicholas M.
    Cheville, John C.
    Thompson, R. Houston
    Pantuck, Allan J.
    Russo, Paul
    Cheng, Emily H.
    Lee, William
    Tickoo, Satish K.
    Ostrovnaya, Irina
    Creighton, Chad J.
    Papaemmanuil, Elli
    Seshan, Venkatraman E.
    Hakimi, A. Ari
    Hsieh, James J.
    [J]. JCI INSIGHT, 2017, 2 (12)
  • [5] Sarcomatoid renal cell carcinoma - An examination of underlying histologic subtype and an analysis of associations with patient outcome
    Cheville, JC
    Lohse, CM
    Zincke, H
    Weaver, AL
    Leibovich, BC
    Frank, I
    Blute, ML
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2004, 28 (04) : 435 - 441
  • [6] Validation by calibration of the UCLA Integrated Staging System prognostic model for nonmetastatic renal cell carcinoma after nephrectomy
    Cindolo, Luca
    Chiodini, Paolo
    Gallo, Ciro
    Ficarra, Vincenzo
    Schips, Luigi
    Tostain, Jacques
    de la Taille, Alexandre
    Artibani, Walter
    Patard, Jean Jacques
    [J]. CANCER, 2008, 113 (01) : 65 - 71
  • [7] Follow-up for Clinically Localized Renal Neoplasms: AUA Guideline
    Donat, Sherri M.
    Diaz, Mireya
    Bishoff, Jay Todd
    Coleman, Jonathan A.
    Dahm, Philipp
    Derweesh, Ithaar H.
    Herrell, S. Duke, III
    Hilton, Susan
    Jonasch, Eric
    Lin, Daniel W.
    Reuter, Victor E.
    Chang, Sam S.
    [J]. JOURNAL OF UROLOGY, 2013, 190 (02) : 407 - 416
  • [8] Eble J., 2004, WHO CLASSIFICATION T
  • [9] Fuccio C, 2014, CLIN NUCL MED, V39, pE320, DOI 10.1097/RLU.0000000000000382
  • [10] Patterns of tumor recurrence and guidelines for followup after nephron sparing surgery for sporadic renal cell carcinoma
    Hafez, KS
    Novick, AC
    Campbell, SC
    [J]. JOURNAL OF UROLOGY, 1997, 157 (06) : 2067 - 2070
1234